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mTORDespite microsurgical repair, recovery of function following peripheral nerve injury is slow and often
incomplete. Outcomes could be improved by an increased understanding of the molecular biology of
regeneration and by translation of experimental bioengineering strategies. Topographical cues have been
shown to be powerful regulators of the rate and directionality of neurite regeneration, and in this study
we investigated the downstream molecular effects of linear micropatterned structures in an organotypic
explant model. Linear topographical cues enhanced neurite outgrowth and our results demonstrated that
the mTOR pathway is important in regulating these responses.
mTOR gene expression peaked between 48 and 72 h, coincident with the onset of rapid neurite out-
growth and glial migration, and correlated with neurite length at 48 h. mTOR protein was located to glia
and in a punctate distribution along neurites. mTOR levels peaked at 72 h and were significantly
increased by patterned topography (p < 0.05). Furthermore, the topographical cues could override phar-
macological inhibition. Downstream phosphorylation assays and inhibition of mTORC1 using rapamycin
highlighted mTORC2 as an important mediator, and more specific therapeutic target. Quantitative
immunohistochemistry confirmed the presence of the mTORC2 component rictor at the regenerating
front where it co-localised with F-actin and vinculin. Collectively, these results provide a deeper under-
standing of the mechanism of action of topography on neural regeneration, and support the incorporation
of topographical patterning in combination with pharmacological mTORC2 potentiation within biomate-
rial constructs used to repair peripheral nerves.
Statement of Significance
Peripheral nerve injury is common and functionally devastating. Despite microsurgical repair, healing is
slow and incomplete, with lasting functional deficit. There is a clear need to translate bioengineering
approaches and increase our knowledge of the molecular processes controlling nerve regeneration to
improve the rate and success of healing. Topographical cues are powerful determinants of neurite out-
growth and represent a highly translatable engineering strategy. Here we demonstrate, for the first time,
that microtopography potentiates neurite outgrowth via the mTOR pathway, with the mTORC2 subtype
being of particular importance. These results give further evidence for the incorporation of microtopo-
graphical cues into peripheral nerve regeneration conduits and indicate that mTORC2 may be a suitable
therapeutic target to potentiate nerve regeneration.
 2017 The Authors. Published by Elsevier Ltd on behalf of Acta Materialia Inc. This is an open access
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Peripheral nerve injury is common secondary to trauma or onco-
logical resection, is functionally devastating, and confers a signifi-
cant socioeconomic cost [1]. Despite the innate regenerative
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injury remains slow and incomplete [2]. The extent of regeneration
depends on the intrinsic growth capacity of the neurons, and envi-
ronmental cues that regulate the temporospatial activation of inhi-
bitory and pro-regenerative signalling cascades [3]. The current
surgical gold standard for the treatment of a gap defect is timely
reconstruction using an autologous nerve graft [4]. This provides
cues in the form of natural anatomical internal topography, extra-
cellular matrix, and Schwann and other support cell populations
[5]. However, limitations include size mismatch, inadequate donor
nerve length, sub-optimal internal topography, and donor site mor-
bidity [6]. Currently available FDA/CE approved alternatives fail to
surpass outcomes achieved using autologous nerve grafts [7].
1.1. Biophysical regulation of the nerve healing microenvironment
The ability of natural and engineered topographical cues to reg-
ulate cell phenotype and function is well described [8–18]. Direc-
tional control of peripheral nerve regeneration has been achieved
in 2D and 3D, and is a key strategy in the design of a bioengineered
nerve conduit [19]. Understanding the downstream mechanism of
action of these pro-regenerative environmental cues informs bio-
material design and engineering, but also reveals mechanistic
understanding relevant to identifying therapeutic biological targets
for neuroprotection, or to enhance the rate and directionality of
axonal regrowth across the site of repair and to the target organs.
1.2. The role of topography
Topographical cues alter cell shape and may act in concert with
biochemical environmental cues. The mechanism of cellular
response to topographical cues is cell and topography type specific
and its detail have yet to be fully elucidated [9,20]. However, given
the ability to engineer topographies with nano- and micro-scale
precision, an increased appreciation of these responses will have
wide ranging implications in the design of the next generation
nerve conduits [19].
Previous studies have identified that phosphoinositide
3-kinase/Akt/mammalian target of rapamycin (P13K/Akt/mTOR)
signalling, mitogen-activated protein kinase (MAPK) signalling,
and CrAT dependent pathways are of importance in neural
regeneration. Carnitine O-acetyltransferase (CrAT) is an enzyme
involved in mitochondrial regulation and is highly active in
neuronal cells [21]. Two previously identified putative adjuvant
pharmacotherapies are the CrAT substrates N-acetyl-cysteine and
L-acetyl-carnitine [22], which enhance mitochondrial function
and prevent neuronal cell death following injury [22,23]. The
mammalian target of rapamycin signalling pathway, mTOR, is a
major regulator in neural regeneration and co-ordinates responses
to growth factors, hormones, neurotransmitters and stress, making
mTOR signalling a strong candidate for regulation of neuronal
response to topographical cues.
mTOR is a highly conserved serine threonine kinase [24,25] that
exists in two distinct complexes mTOR complex 1 and mTOR com-
plex 2 (mTORC1, mTORC2 respectively). mTORC1 is rapamycin
sensitive and responsible for the regulation of cell growth, mRNA
biogenesis and ribosomal translation [26]. mTORC2 contains a ric-
tor complex in place of mTORC1’s raptor complex, and has been
shown to regulate cytoskeletal remodelling in non-neuronal cell
types [26].
Upstream regulation of mTOR by other environmental cues has
been described [27–29], however it is not known if the neuronal
response to topography is mediated by mTOR. Downstream phos-
phorylation of S6 and Akt(Ser473) are used as surrogate markers of
mTORC1 and mTORC2 activity respectively [30]. This study aimed
to investigate the relevant downstream molecular response ofrodent primary sensory neurons to topographical cues. We hypoth-
esised that mTOR is important in mediating this response. We per-
formed phosphorylation assays and inhibited mTOR using
rapamycin in order to investigate this. Rapamycin is a macrolide
antifungal agent used to prevent rejection following transplanta-
tion [31]. In vitro and in vivo preclinical studies provide contrasting
evidence as to the impact of rapamycin on nerve regeneration
[32–34] and to date it has not been investigated by clinical trials
in this context. Unravelling the regulatory mechanisms provides
further characterisation of a useful in vitro model of nerve
repair, and seeks future targets for therapeutic manipulation by
pharmacology or bioengineering of nerve conduits [35,36].2. Materials and methods
2.1. Polymer fabrication, surface treatment and characterisation
To study the effect of topography in vitro, micro-patterned and
flat polydimethylsiloxane (PDMS) constructs were cast. UV pho-
tolithography was used to pattern SU-8 photoresist on a silicone
master wafer to be used as a template for fabrication of PDMS sub-
strates. Pre-defined master wafer parameters (parallel grooves,
12.5 lm width  5 lm height) were used, based on previous stud-
ies [37,38]. The master wafer was centred on a casting jig and
secured with screws. A PDMS mix (ratio of 10:1 base: curing agent,
Silicone elastomer 184 SYLGARD) was homogenised, degassed in
a vacuum chamber for 20mins, injected into the casting jig, and
cured for 2 h at 80 C. Flat substrates were constructed using the
same technique with an un-patterned master. The biocompatible,
biodegradable polymer poly-e-caprolactone (PCL) was also spin
coated onto the surface of a SU-8 master generating identical
micropatterns in a polymer suitable for future nerve conduit devel-
opment. Air plasma treatment of the surfaces was used to increase
hydrophilicity (Harrick Plasma PDC-002 Plasma Cleaner 29.6W,
1 min).
Following sterilisation by immersion in 70% ethanol for 30 min
polymer surfaces were incubated in 13 lg/mL poly-L-lysine (PLL;
MW 100,000, Sigma P1274) in reverse osmosis (RO) water for
30 min. Surfaces were then washed thrice with 1% PBS and blown
dry with filtered (0.4 lm) air prior to use. Scanning electron micro-
scopy (SEM) was performed with a Hitachi S800 field emission
SEM at an accelerating voltage of 6 kVin SEM (high-vacuum) mode.
Polymers were mounted on SEM sample holders and sputter-
coated with gold prior to imaging to characterise substrate sur-
faces. Water contact angle was measured to confirm increased
hydrophilicity following surface treatment using a KSV CAM 100
goniometer (KSV Instruments, Finland).2.2. DRG organotypic explant
All work was carried out in strict accordance to the Home Office
Animals (Scientific Procedures) Act 1986. Neonatal Sprague
Dawley rats were euthanized by euthatal injection (Merial,
200 mg/ml, 500 mg/kg). Dorsal root ganglia (DRG) were harvested
using careful microsurgical technique under binocular magnifica-
tion. Explants were cultured at 37 C, 5% CO2 in L-15 media
(Sigma-Aldrich) supplemented with 10% FBS (Sigma-Aldrich),
50 lg/ml N-Acetyl-Cysteine (Sigma-Aldrich), 1% Penicillin-
Streptomycin (GE Healthcare) and 10 ng/ml NGF 2.5S (Invitrogen).
Rapamycin (Sigma-Aldrich) was reconstituted in dimethyl sulfox-
ide (DMSO, Sigma-Aldrich) and delivered daily in culture media
to treated groups at 1 lM. An equivalent volume of DMSO
(0.0036% v/v) was delivered in vehicle control groups. Media was
changed every 24 h in all conditions. Standard incubator settings
of 37 C, 5% CO2 were maintained throughout the experiment.
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Neurite outgrowth and cell migration was measured at 2, 24,
48, 72 h, and at 5 and 10 days following explantation using 10x
light microscopy (Motic AE31, Scion digital camera) and scanning
fluorescence microscopy (Olympus, Axiovert). The outlines of the
cluster of cell bodies within the ganglion and the extent of the
emerging neurite front were defined and images analysed using
Fiji software [39]. Based on the Herbert equation [40], total DRG
explant area, maximal neurite length (defined as the furthest
extension of a pathfinder neurite), and total surface area covered
by neurites was quantified.
2.4. Quantitative real time PCR analysis
At the predefined time points DRGs were removed from culture
and placed in 20 ll RNAlater (Life Technologies, Paisley), then
stored at 80 C prior to processing. Immediately harvested DRGs
were subject to the same process and used as a day 0 baseline
control. Analysis of gene expression was performed using the
2DDCT method [41] normalising expression to GAPDH and day 0
levels.
Total RNA from each time point was extracted using a Qiagen
RNeasy micro kit according to the manufacturer’s protocol. DRGs
were removed from cold storage and added to a solution of
350 ml of lysis buffer with b-mercaptoethanol plus 20 ng of carrier
RNA (as described in the RNeasy Handbook, Qiagen) added. A triple
disruption and homogenization technique was used, combining
30 s vortex, 5x passes with 26-gauge needle and 2 min centrifuga-
tion. An equal amount of RNA from each sample was used for cDNA
preparation using the QuantiTect RT-PCR kit from Qiagen following
the Qiagen protocol. qRT-PCR was carried out using the Quantifast
SYBR Green kit (Qiagen) and a 7500 Real Time PCR system (Applied
Biosystems). A minimum of 3 biological and 3 technical replicates
was tested at each time point. The primer sequences (Table 1) for
the genes were derived from Primer-BLAST [42] and validated by
dissociation curve/melt curve analysis.
2.5. Immunohistochemistry and protein localisation
Following specified time periods DRGs were fixed in 4%
formaldehyde/PBS (1%) for one hour at 37 C. DRGs were then per-
meabilised in a buffer solution (10.3 g sucrose, 0.292 g NaCl, 0.06
MgCl2, 0.476 g HEPES, 0.5 ml Triton X-100 per 100 ml PBS) for
one hour at 4 C. This solution was exchanged for a blocking solu-
tion (1%BSA/PBS) for one hour at 37 C. A cocktail of primary anti-
bodies was applied (1:100 mouse anti-beta3 tubulin (Santa Cruz),
1:100 goat anti-mTOR (Cell Signalling) OR 1:100 goat anti-S100
(Abcam), OR 1:100 mouse anti-vinculin (Sigma), 1:100 rabbit
anti-rictor (Abcam), 1:50 fluorescein-phalloidin (Invitrogen)
(diluted in 1%BSA/PBS) and DRGs were incubated overnight at
4 C. S100 was used as a Schwann cell marker. Samples were
washed thrice (PBS/0.5% Tween-20; 5 min per wash), prior to over-
night incubation at 4 C with secondary antibody cocktail (1:100
biotinylated anti-mouse antibodies, Vector Laboratories, andTable 1
Forward and reverse primer sequences used for polymerase chain reaction.
mTOR FOR 50 GCA GCA TGG GGT TTA GGT C – 30
REV 50 CCC GAG GAA TCA TAC ACG TC – 30
MAP3K12 FOR 50 GTC TTC ACC TGC CTG TAC CC – 30
REV 50 GGT TCC GAG GTT TGC TCT T – 30
CrAT FOR 50 TAG CTT TTG CTC CCA GAA CC – 30
REV 50 GGC CTT AAA TCG ACC AGA CA – 30
GAPDH FOR 50 GGG TGT GAA CCA CGA GAA AT – 30
REV 50 ACT GTG GTC ATG AGC CCT TC – 301:300 donkey Texas red anti-goat, Invitrogen). Total incubation
time was 18 h to allow penetration into the DRG tissue. Fluorescein
Streptavidin 1:100 (Vector Laboratories) in 1% BSA/PBS was then
added to the sample for 30 min at 4 C and washed again. Samples
were washed thrice, prior to being mounted with DAPI anti-fade
medium (Vecta-Shield, Vector Laboratories, Peterborough UK)
and viewed by fluorescence microscopy. Quantitative analysis
was performed using FIJI software [39].
2.6. In-Cell western
For quantitative immunofluorescence measurement DRGs were
fixed overnight and permeabilised for one hour, at 4 C. Incubation
times were optimised to enable staining of the cell somata
throughout the body of the DRGs. Following blocking (Odyssey
Blocking Buffer) for 2 h at room temperature samples were incu-
bated overnight in primary antibody cocktail (mTOR, pmTOR Ser
2448, or Akt, pAkt Ser 473 (Cell Signalling) at 1:1000 concentra-
tion). Following 5 washes with PBS Tween (0.5%) DRGs were incu-
bated for a further 12 h with species-specific secondary antibody
or CellTag conjugated to IR-Dye of 700 or 800 nm emission wave-
length. An Odyssey CA Imaging System (Li-COR Biosciences) was
used to quantify signal intensities. Settings were optimised and
maintained throughout individual experimental runs. Signal inten-
sities were normalised to CellTag or to each other for phosphoryla-
tion ratios [43,44].
2.7. Statistical analysis
Statistical analysis was performed using GraphPad Prism
version 7.0b (Graphpad Software). Results are presented as
mean ± SEM from a minimum of 3 individual DRG explants.
Student t-test or Mann-Whitney test (non-parametric) and
repeated measure one-way analysis of variance (ANOVA) or
Friedmans test (non-parametric), were used to determine statisti-
cal significance between data, Spearman correlation was calculated
for co-localization and p < 0.05 was considered significant and
standard reporting denoted by asterisks (p < 0.05 = ⁄, p < 0.01⁄⁄,
p < 0.001⁄⁄⁄, p < 0.0001⁄⁄⁄⁄).3. Results
3.1. DRG neurite outgrowth is regulated by topography
For evaluation of neurite outgrowth in response to topographi-
cal cues micro-fabricated PDMS and PCL surfaces were produced
with 12.5 mmwide grooves (Supplementary Fig. 5A), flat substrates
were used as controls. Surface air plasma treatment rendered sur-
faces more hydrophilic (Supplementary Fig. 5B). The dorsal root
ganglion (DRG) model was used for neurite outgrowth analysis,
providing a 3D organotypic explant that more closely reflects the
heterogeneous in vivo environment compared to dissociated neu-
ronal cultures (Fig. 1A). A characteristic phenotypic response to
topography was observed in the DRG explants (Fig. 1B). Topo-
graphical guidance cues resulted in highly directed neurite out-
growth, and significantly increased maximal neurite length from
the third day in culture, compared to flat controls (Fig. 1C). Net-
works of DRGs grown on flat surfaces covered a greater surface
area at day 3, with no difference in network area between sub-
strates by day 10 (Supplementary Fig. 1).
3.2. Gene expression time course and effect of topography
Candidate gene expression was measured in each DRG sample
and temporal regulation demonstrated (Fig. 2). mTOR gene
Fig. 1. DRG explant cultured for 72 h on flat (A) or patterned (B) PLL coated PDMS substrates with 10 mg NGF/ml and stained for ß3-tubulin (green) and DNA (blue). A) Typical
outgrowth on a flat substrate showing right turning spiral arrangement of axons. B) The topographical cues (12.5 lm wide, 5 mm deep) direct neurite outgrowth. Scale bars
200 lm. C) Plot of maximum neurite length versus time. Neurite length increases more rapidly on flat surfaces, until day 2, after which time topographical cues enhance
neurite outgrowth (n  9, Mann-Whitney mean and SEM p < 0.05, **p < 0.01).
Fig. 2. Timeline of candidate gene expression in DRG grown on grooved or flat substrates. Fold change presented normalized to day 0 control. All individual data points
plotted alongside mean and SEM.A) mTOR: There was transient upregulation of mTOR on flat and grooved surfaces following injury. mTOR was significantly upregulated on
grooved topography compared to flat substrates by day 2 (n  3, t-test, p = 0.004). Maximal upregulation was detected at day 3 with return to baseline by day 4. B) MAP3K12:
Early increased transcription was demonstrated on the flat substrates (n  3, t-test, p = 0.002). Thereafter no statistically significant difference was seen between flat and
grooved substrates. At all subsequent time-points there was increased expression on flat and grooved substrates compared to day 0 baseline. C) CrAT: upregulation from
baseline was demonstrated on both flat and grooved substrates. No significant difference was detected between substrates, however, there is sustained upregulation over the
duration of the study (Expression Day 1 vs. Day 4 Flat p = 0.0009, Grooved p = 0.03). One data point is an outlier (D3F = 17) and is off of scale.
S.E. Thomson et al. / Acta Biomaterialia 60 (2017) 220–231 223expression increased to a peak at 72 h before returning to baseline
and was significantly increased on grooved surfaces (p = 0.004)
(Fig. 2A). We also investigated the impact on two other genes of
known importance in nerve regeneration, MAP3K12 and CrAT.
MAP3K12 gene expression showed less clear temporal variation
and was upregulated on flat, but not grooved, substrates on day
1 (p = 0.002) (Fig. 2B). CrAT expression was increased over the
time-course studied and there was no impact of topography upon
CrAT expression (Fig. 2C).3.3. Transient mTOR gene expression coincides with the period of rapid
neurite outgrowth
As the greatest up regulation was detected in the mTOR tran-
scripts we subsequently investigated this pathway in more detail
over a ten-day timeline. By day two mTOR expression was upreg-
ulated on both flat and grooved substrates and mTOR gene expres-
sion correlated with neurite length (Fig. 2A Spearman rank
correlation, r = 0.7920, p = 0.0012, n  12). Transcript levels were
224 S.E. Thomson et al. / Acta Biomaterialia 60 (2017) 220–231significantly greater on grooved substrates (n  3, t-test, p = 0.004).
Maximal expression occurred 3 days following injury, and was
coincident with the onset of a period of rapid neurite outgrowth
and support cell activity (Fig. 3B, C). Time-lapse videos demon-
strating outgrowth are available within supplementary files.
3.4. mTOR is upregulated in response to topography in both neurites
and support cells
mTOR protein staining was located in a punctate manner along
outgrowing neurites and also within distinct S100 positive
(Schwann/satellite cells) and negative support cell subpopulations.
Staining was demonstrated throughout the neuronal perikarya and
support cells in the ganglia (Fig. 4). Li-COR In-Cell Western (Fig. 5)
was used to quantify total and active (phosphorylated) mTOR
protein and normalised to CellTag (unspecific protein stain used
for normalisation, Li-COR) [43]. At the 72-h time point total
mTOR expression was increased on grooved topography
compared to flat surfaces (p = 0.02), as was the total active
phosphorylated protein (p = 0.03). These results confirmed that
the detected changes in gene expression correlated with increased
protein translation.
3.5. Topographical cues produce differential responses to rapamycin
The mTOR pathway was further interrogated using the pharma-
cological inhibitor rapamycin. The activation of downstream path-Fig. 3. A) Timeline of mTOR activation, neurite extension and support cell activity of rege
neurite length in the first 2 days (Spearman correlation, r = 0.7920, 95% confidence inte
Fig. 3A. Each point represents an individual DRG, day 1 (d), day 2 (h). Columns B, C) Tim
cells (examples indicated by *) and axonal projections (>) and are captured, with increa
support cell movement is random. Highly directed neurite outgrowth and support cell
online. Scale bar 100 lm.ways was studied to identify critical elements in the response to
topography - here phosphorylation of S6 and Akt (Ser473) were
used to monitor mTORC1 and mTORC2 activity respectively [30].
Pharmacological inhibition of mTOR by rapamycin was con-
firmed by significant reduction in pS6 levels (Fig. 6A), an effect that
was potentiated by culture on flat surfaces (despite comparable
initial baseline levels on both substrates). Use of grooved sub-
strates appeared to decouple the link between mTORC1 and
mTORC2 levels. When compared to flat surfaces, grooved topogra-
phy supported increased baseline Akt phosphorylation (mTORC2
activity marker), and provided resistance against the effect of
mTORC1 inhibition by rapamycin (Fig. 6B).
A differential response to rapamycin treatment was consis-
tently observed on grooved vs. flat substrates. Rapamycin treat-
ment reduced the number of support cells (Fig. 7A) and maximal
neurite length (Fig. 7B) on flat surfaces, but had no effect on
grooves. Taken together these results demonstrate a differential
regulation of the mTORC1/S6 and mTORC2/Akt pathways by topo-
graphical cues.
3.6. Localisation of mTORC2 component rictor at the regenerating
front
To investigate the hypothesis that mTORC2 is important at the
regenerating front we stained for rictor, vinculin, F-actin and focal
adhesion kinase (FAK) (Figs. 8, 9 and Supplementary Figs. 2, 3, 4).
We found that vinculin and rictor co-localised at growth conesnerating DRG neurons cultured with 10 ng/ml NGF. mTOR levels correlate well with
rvals, p < 0.01, n = 13). The neurite length was measured for a subset of DRGs from
e-lapse images of DRG regeneration on flat (C) and grooved substrates (D). Support
sed activity demonstrated at 60hours. On the flat surface (C) axonal outgrowth and
movement on 12.5um linear topography (C). Supplementary movies available to
Fig. 4. DRG cultured on flat substrates stained for mTOR, S100 and DNA. A) mTOR protein was located within the portion of the DRG explant containing neural cell bodies and
in a punctate manner along regenerating neurites B) S100 positive cells, C) cell nuclei. Magnification of the area indicated in A in D-G. D) S100 positive cells. Arrows indicate
the same S100 negative, mTOR (E) positive cells. E) mTOR positive cells. mTOR was detected within distinct S100 positive (*) and negative (arrows) support cell
subpopulations in D and E. F) DNA image showing all cells. G) Merge of mTOR (red), S100 (green) and DNA (blue) images. Further analysis identified a subpopulation of the
mTOR+/S100- cells as ED1 positive macrophages (data not shown). Scale bar 400 lm (A-C), 100 lm (D-G).
Fig. 5. mTOR phosphorylation on flat (F) and grooved (G) substrates following 72 h in culture (NGF 10 ng/ml). A) mTOR and phosphorylated (pmTOR) protein were
significantly increased in DRGs grown on grooved topography (t-test, mTOR p = 0.02, pmTOR p = p = 0.03). B) Ratio of pmTOR/mTOR plotted for flat and grooved samples at
72 hs shows that there was no difference in the ratio of phosphorylated mTOR in either condition.
S.E. Thomson et al. / Acta Biomaterialia 60 (2017) 220–231 225(Fig. 8), irrespective of topography in all neurites. Quantitative
analysis demonstrated close correlation in normalized grey values
of rictor and vinculin on flat and grooved substrates (Fig. 8). The
distribution along neurites was differentially regulated by topogra-
phy. The tip of the growth cone was identified by peak F-actin grey
value and an absence of rictor, with peak rictor grey scale localised
just proximal to this point (Fig. 9). In DRGs stained for rictor and
vinculin, but not actin (Fig. 8) it is likely that the tip of the growthcone was not detected, instead rictor and vinculin peak normalised
grey value occurred at the same point.4. Discussion
Improving the rate and directionality of nerve regeneration is a
significant challenge. A combinatorial approach employing
Fig. 6. Impact of rapamycin treatment after 48 h of culture on S6 ribosomal protein and Akt if cultured on flat or grooved substrate. DRG were maintained with 10 ng NGF/ml.
A) Ratio of phosphorylated S6 ribosomal protein (pS6) to all S6 ribosomal protein. Pharmacological inhibition of mTOR by rapamycin was confirmed by significant reduction
in ratio of phosphorylated S6. Despite similar baseline ratios a greater reduction of S6 activity in response to rapamycin treatment was seen in DRGs cultured on flat
substrates (Mann-Whitney, p = 0.0043, n = 5). B) Ratio of phosphorylated Akt over total Akt in relation to rapamycin treatment. Baseline pAkt ratios (indicating mTORC2
activity) were significantly greater in DRGs cultured on topography. Inhibition of mTORC1 by rapamycin resulted in increased mTORC2 activity on flat, but not on grooved
substrate.
Fig. 7. Support cell number (A) and neurite outgrowth (B) in response to rapamycin treatment. 1 mM rapamycin consistently reduced the number of support cells on flat
surfaces (F) compared to grooved surfaces (G) (P = 0.0021 Friedman test – non-parametric equivalent of one-way ANOVA), this was particularly evident by 72 h (t-test, with
Welch’s correction, RAPA F vs. RAPA G at 72 h, p = 0.0003, N > 7). There is a trend toward increased support cell number on grooved surfaces (grey symbols) compared to their
flat counterparts (black symbols). Grooved surfaces consistently increase neurite outgrowth compared to flat surfaces (p = 0.005 for NGF, p = 0.285 for DMSO, p = 0.028 for
RAPA). (72 h). Rapamycin treatment significantly reduced neurite outgrowth on flat surfaces (N) compared to DMSO controls (d) (t-test, with Welch’s correction, p = 0.0003),
but grooves did not show this phenomenon.
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demonstrates that linear topographical cues influence the network
shape and directionality of DRG axons, as well as the time course of
gene expression.
Our findings concur with previous reports that linear topo-
graphical cues, whether in the form of microgrooves (as in the cur-
rent study), fibres, or channels enhance neurite outgrowth [45–50]
and we now provide new detail on the molecular response. Previ-
ous studies demonstrate DRG neurons respond to a range of linear
guidance cues (width 1–100 lm) [51–53]. Anisotropic linear cues
(12.5 lm in width and 5 lm in depth) and the organotypic explant
model were used in this study. This facilitated the study of the
response and interaction of several cell types to topographical
cues, as is more representative of the in vivo environment. Sch-
wann cells aligned to the topography, in keeping with previous
findings [46,54], and in addition we found that topography
increased the migration and number of support cells. This wouldlikely cause directional deposition of extracellular matrix mole-
cules and could lead to haptotactic cues that are known to enhance
directional axon outgrowth [55,56].
4.1. Topography modulated expression of candidate genes
Understanding the downstream molecular responses to topog-
raphy informs the design of future bioengineered conduits. We
investigated three selected candidate genes of known importance
in nerve regeneration, with rat:human homology and the potential
for pharmacological modulation. The highly conserved MAPK path-
way is of therapeutic importance since it is required for successful
regeneration [57,58]. MAP3K12 has several contrasting roles and
knowledge of its temporospatial activity remains incomplete. It
has been demonstrated that despite acting upstream of C-Jun ter-
minal kinase (JNK) as a pro-regenerative switch, a reduction in
MAP3K12 protects neurons from apoptosis after nerve injury and
Fig. 8. DRG cultured on topographically patterned (A-G) and flat (F-I) substrates stained for vinculin (A, B, F, G), rictor (mTORC2) (C, H) and DNA (D, I). In the merged images E
and J) Rictor (red) and vinculin (green) co-localize at growth cones (yellow), with maximal intensities close to the leading edge of the growth cones (yellow). Scale bar:
100 lm in images E and J applies to B-E and G-J respectively; 200 lm in whole DRG images A and F. K) Plot of normalized grey value of rictor (d) and vinculin (j) against
relative distance along axon, from the tip (0) towards the DRG body (1). Values for flat surfaces are in green, topographically patterned in blue. Rictor and vinculin co-localize
at the regenerating tip in DRGs cultured on both substrates and the normalized grey values demonstrate correlation (Spearman correlation between vinculin and rictor for
grooves r = 0.79, p < 0.05, flat r = 0.75, p = 0.063, n = 36).
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[59–62]. In this model an early increase in MAP3K12 expression
was found, with significantly raised transcript levels detected in
DRGs cultured on flat substrates. However, despite continual
expression MAP3K12 transcript levels were consistently reduced
on topography, as opposed to flat, substrates. This indicates that
topography may act to reduce activity of the MAP3K12 pathway
and warrants further investigation.
Upregulation of the carnitine acetyl transferase (CrAT) pathway
confers neuroprotection following injury [22,63]. In keeping with
the increased metabolic demand associated with growth, CrAT
expression was consistently elevated in DRGs cultured in both con-
ditions, and levels increased temporally (Fig. 2C) [64,65].
The most profound transcript up regulation was observed in
mTOR, and hence became the focus of this study.
4.2. mTOR is of critical importance within the first 72 h following
injury
A large body of literature highlights the importance of the
mTOR pathway in nerve injury and repair, and describes upstream
regulation of mTOR by stress, growth factors, hormones and neuro-
transmitters [27,33,66–68]. However, the role of mTOR in mediat-ing the response of regenerating neurons to topography and
whether mTOR plays a role locally at the injury site, or distantly
in the cell body had not been fully ascertained [67,68]. This study
provides new evidence upon the pattern of change in mTOR
expression within the perikarya and growth cones, and confirms
mTOR as an important downstream mediator of topographical
cues. A consistent, transient, differential response in
regeneration-related gene and protein levels was demonstrated
between DRG cultured upon linear topographies and flat control
surfaces.
Intrinsic mTOR levels decline with age and are correlated with
decreased growth capacity in retinal ganglion cells [28]. Con-
versely, deletion of upstream mTOR inhibitors result in increased
neural regeneration [27,33]. This study demonstrates that linear
microtopographical cues temporarily increased basal mTOR levels,
peaking on day 3. These findings are in agreement with Abe et al.
[33] who demonstrated transient activation of mTOR in DRG
immediately after injury, with return to basal levels four days fol-
lowing injury. Love et al. evaluated axonal mTORC1 levels in vivo at
early time points, and detected an increase at six hours following
injury, attributed to local translation of protein transcripts in the
axon [68]. Our time course and localisation detail indicates that
mTOR is of importance in the initiation of outgrowth.
Fig. 9. A) DRG cultured on topographically patterned and flat substrates stained for A, B, F, G) F-actin, C, H) rictor and D, I) DNA. E) Rictor (red) and F-actin (green) staining
seen throughout neurites, with maximal co-localization at growth cones (yellow). Scale bar 200 lm in magnified images, 500 lm in whole DRG image. K) Plot of normalized
grey value against distance along axon from tip towards cell body in DRGs cultured on topography (K) and flat substrates (L). Quantitative analysis demonstrates peak F-actin
grey value at the tip of the growth cone, peak rictor grey scale is localized just proximal to this however relative intensity change along the neurite is not as striking as that
seen on grooved surfaces (mean and SEM, n = 12). Grey values normalized to the maximum detected along the whole neurite.
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of mTORC1
An earlier and increased up-regulation of total mTOR transcript
and protein levels was detected when DRGs were cultured on
grooved substrates. As mTOR exists in two different complexes,
mTORC1 and mTORC2, their activity was monitored via phospho-
rylation of S6 and Akt(Ser473) respectively [30]. Baseline pAkt
(Ser 473), a read out for mTORC2 [69], was shown to be increased
in DRGs cultured on linear microtopography (Fig. 6) and was asso-
ciated with increased neurite regeneration.
Pharmacological inhibition of mTORC1 reduced support cell
proliferation, migration and neurite elongation on flat surfaces,
however interestingly rapamycin had no impact on regeneration
along linear topographical cues. Taken together these findings indi-
cate that mTORC2 is more important in mediating the response to
linear topography, whereas regeneration on flat surfaces is more
reliant on intact mTORC1 activity.
Although much is known about how external environmental
cues (e.g. nutrients, growth factors, energy and stress) regulate
mTORC1, surprisingly fewer papers concern the response of
mTORC2 to these stimuli [70].Downstream of mTORC2, the pathway response involves RAC,
Rho [71–73] PKC-a and SGK1. In retinal epithelia and CNS neurons
rho GTPases and protein kinase C, both regulated by mTORC2, have
been demonstrated to be of importance in mediating the response
to micropatterning [74,75]. Further studies of the roles of these
pathways are necessary to delineate their precise roles in periph-
eral nerve axon guidance and growth cone dynamics [76].
Akt is of known importance in regulating growth and prolifera-
tion, by mediating many of the cellular effects of PI3K [77,78].
However, many of the effects of Akt on other processes (e.g. migra-
tion) appear to be independent of PI3K [79]. mTORC2 is necessary
for neuronal protrusion in C. elegans and in this model system
cdc42 is an important mediator, acting upstream of PI3K, and
known to be more critical than mTORC1 [76]. This study supports
these findings, and furthermore indicates that mTORC2 is tran-
siently involved in coordinating neuronal response to topographi-
cal cues.
A possible mechanism through which mTORC2 could perform
this action would be through interactions at point contacts, which
are similar to focal adhesions. Point contacts are involved in axon
path finding and organised throughmembrane associated proteins,
which are phosphorylated at tyrosine residues [80,81]. It is logical
S.E. Thomson et al. / Acta Biomaterialia 60 (2017) 220–231 229that these could be initiated through topography as grooves have
previously been demonstrated to initiate tyrosine phosphorylation
of membrane proteins [82,83].
4.4. Focal adhesions
Focal adhesions (FAs) are multifunctional protein agglomerates
that mediate cell–ECM adhesion, force transmission, cytoskeletal
regulation and signalling [83,84] and form along physical features
such as groove/ridge transitions [82]. As such, topographical cues
present areas for FA formation to be initiated, causing cytoskeletal
rearrangement, and can in other cell types act through both direct
and indirect mechanotransduction to alter gene transcription
[12,82]. Although much is known about focal adhesion regulation
in non-neuronal cells it is recognised that a more detailed molecu-
lar insight is required into howmechanical signals, encountered by
the growth cone, initiate signalling [85–87]. Schulte et al. showed
how the cellular interaction with the nanotopographical features
can promote neuronal differentiative behavior in PC12 cells and
hippocampal neurons [86,87]. This is realised by the impact of
the neuron/nanotopography interaction on mechanotransductive
processes, such as FA maturation (restriction to point contact
dimensions), cytoskeletal organisation and mechanics (i.e. stress
fibre formation and cell rigidity). This has the net effect of polari-
sation, growth cone stabilisation and potentiated neuritogenesis.
Furthermore, it was demonstrated that the response of neuronal
cells to topography resulted in increased RhoA and cdc42, indepen-
dent of NGF and TrKA. Both RhoA and cdc42 are downstream of
mTORC2 and are known to activate FAK [86]. Our finding that
mTORC2 is important in mediating the response to topography
provides further molecular explanation, extending their results.
In other cell types, predominantly stem cells, it has been demon-
strated that mTORC2 co-localises with Akt at newly formed FAs,
and becomes associated with vinculin when cells are exposed to
strain to mediate cytoskeletal reorganization, independent of
PI3K [79,88]. Yang et al. demonstrated that a hierarchical patterned
substrate influenced the fate of neural stem cells [89]. The co-
localisation of FAK and vinculin supports the importance of FAs
in mediating the differentiative process, which was reduced by
the addition of integrin antibodies and ROCK inhibition [89]. Using
co-localisation we demonstrated that mTOR was present in a punc-
tate manner along neurites and at the regenerating front, which
may represent mTORC2 activity at FAs. In order to test this hypoth-
esis we investigated co-localisation of focal contact molecules FAK,
F-actin and vinculin with rictor, the main component of mTORC2.
We found that rictor co-localised with vinculin, F-actin and FAK
on topography (Figs. 8, 9, Supplementary Figs. 2, 3, 4). The grey
value of vinculin and rictor staining was greatest at the regenerat-
ing front, an effect that was differentially regulated by topography.
F-actin was located at the very tips of exploratory filopodia and ric-
tor co-localised at these points, with peak grey value just proximal
to that of F-actin. Taken in context our data indicates that canoni-
cal mTORC2 signalling occurs within the regenerating front, at the
growth cone. We propose that linear topographical cues act to
increase mTORC2 activity, resulting in the detected phosphoryla-
tion of Akt, both through and independently of mTORC1/PI3K.
There are discrepancies found in the literature regarding the
effect of rapamycin treatment on neuronal regeneration
[32,90,91]. A detailed review reveals that in cases where topo-
graphic guidance was provided (e.g. natural or synthetic fibres/
channels or surface topography), rapamycin increased or had no
impact on neurite outgrowth [32,90,91]. On the other hand, where
there were no surface features nerve regeneration was reduced by
rapamycin [33,92,93]. The differential effect observed by addition
of rapamycin to DRGs cultured on flat or patterned substrates in
this study provides an explanation for these discrepancies. In lightof these findings rapamycin has the potential to have a pro-
regenerative impact, through well-recognised immunomodulatory
effects, if delivered as part of a topographically patterned nerve
conduit.5. Conclusion
Although the mTOR pathway has previously been demonstrated
to regulate neurite response to other environmental factors
[26,31,94,95], its role in mediating response to topography in dor-
sal root ganglia had not previously been described; furthermore
the role of mTORC2 has been relatively overlooked. This study
implicates mTORC2 as an important downstream mediator of
topography in peripheral nerve regeneration. These findings sup-
port the incorporation of linear topographical cues into nerve
repair constructs, and highlights the additional therapeutic poten-
tial if mTORC2/pAkt potentiating agents can be incorporated into
the constructs.
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